Inovio Pharmaceuticals, Inc.

INO

Financials

10-QQ2 ended 06/30/2608/12/26 10-QQ1 ended 03/31/2605/13/26 10-KFY 202503/12/26 10-QQ3 ended 09/30/2511/10/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report10/06/26 8-KCurrent report08/12/26 8-KCurrent report07/31/26 8-KCurrent report07/29/26 8-KCurrent report05/20/26

Prospectuses and Registrations

424B5Prospectus supplement07/30/26 424B5Prospectus supplement07/29/26 S-3Shelf registration07/02/26 S-8Registration of securities for employees05/26/26 424B5Prospectus supplement04/02/26

Proxies

DEF 14ADefinitive proxy04/07/26 DEF 14ADefinitive proxy04/07/25 DEF 14ADefinitive proxy04/11/24 DEF 14ADefinitive proxy11/28/23 PRE 14APreliminary proxy11/17/23

Ownership

SC 13G/ABeneficial ownership (amended)08/12/26 SC 13GBeneficial ownership08/07/26 SC 13G/ABeneficial ownership (amended)08/06/26 SC 13GBeneficial ownership07/31/26 Form 4Insider transaction05/21/26

Other

EFFECTRequest for effectiveness07/10/26 ARSAnnual report to shareholders04/07/25 ARSAnnual report to shareholders04/15/24 EFFECTRequest for effectiveness01/31/24 CORRESPCorrespondence with the SEC01/29/24